Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.75 USD | +5.50% | +11.77% | -8.73% |
18/03 | Forte Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
05/01 | Camac Partners Provides Information to Shareholders | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.73% | 25.87M | |
+4.02% | 106B | |
+7.02% | 23.47B | |
-14.53% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-8.66% | 16.78B | |
+6.57% | 14.41B | |
+35.37% | 12.86B | |
+317.57% | 8.78B |
- Stock Market
- Equities
- FBRX Stock
- News Forte Biosciences, Inc.
- Forte Biosciences : Chardan Capital Upgrades Forte Biosciences to Neutral From Sell Following Recent Selloff, Adjusts Price Target to $3.50 From $4